From: Hyperhomocysteinemia is associated with decreased apolipoprotein AI levels in normal healthy people
Parameters | Control group (n = 1412) | HHcy group (n = 356) |
---|---|---|
Age, y | 41.11 ± 11.44 | 41.25 ± 12.25 |
Gender, Males/Females | 790/622 | 196/160 |
BMI, kg/m2 | 24.33 ± 3.44 | 24.68 ± 3.13 |
SBP, mmHg | 120.34 ± 11.26 | 121.35 ± 11.19 |
DBP, mmHg | 73.04 ± 8.65 | 73.72 ± 8.89 |
TC, mmol/L | 4.89 ± 0.90 | 4.87 ± 0.85 |
LDL-C, mmol/L | 2.83 ± 0.73 | 2.90 ± 0.71 |
HDL-C, mmol/L | 1.29 ± 0.32 | 1.18 ± 0.25** |
TG, mmol/L | 1.12 (0.76–1.71) | 1.28 (0.88–1.97)** |
apoAI, g/L | 1.47 ± 0.25 | 1.38 ± 0.19** |
apoB, g/L | 0.87 ± 0.20 | 0.90 ± 0.20 |
FBG, mmol/L | 5.34 ± 0.36 | 5.38 ± 0.35 |
FINS, μIU/mL | 11.25 (7.40–16.16) | 11.41 (8.39–16.40) |
HOMA-IR | 2.68 (1.74–3.87) | 2.72 (1.97–4.01) |
Homocysteine, μmol/L | 11.04 ± 1.81 | 26.53 ± 13.68** |